Immune Checkpoint Inhibitors and Combinations: Unleashing the Power of Next-Gen Immuno-Oncology

The field of immuno-oncology has revolutionized cancer treatment by harnessing the immune system's power to combat tumours. Immune checkpoint inhibitors (ICIs) have emerged as a game-changer among the remarkable advancements in this domain. ICIs work by blocking the inhibitory signals that prevent immune cells from attacking cancer cells, thereby unleashing the body's natural defence mechanisms. Combining ICIs with other therapies holds tremendous potential to further enhance their effectiveness. To delve deeper into the world of next-generation immuno-oncology and explore the latest advancements in this field, the forthcoming MarketsandMarkets Next-Gen Immuno Oncology Conference is an event not to be missed.

The MarketsandMarkets Next-Gen Immuno-Oncology Conference:
MarketsandMarkets is hosting the Next-Gen Immuno Oncology Conference on the 8th - 9th February 2024 in San Diego, USA. This annual conference has gained significant recognition as a platform for bringing together global experts, researchers, clinicians, and industry professionals to discuss the latest trends, innovations, and challenges in immuno-oncology. With a primary focus on immune checkpoint inhibitors and combinations, the conference aims to foster collaboration, knowledge sharing, and networking opportunities within the immuno-oncology community.

Benefits of Attending:
By participating in the MarketsandMarkets Next-Gen Immuno-Oncology Conference, attendees can unlock many benefits. Here are a few compelling reasons why you should mark your calendar for this event:
• Cutting-Edge Insights: Gain access to cutting-edge research, emerging trends, and groundbreaking discoveries in immuno-oncology. Learn from leading experts who will share their knowledge and experience through keynote presentations, panel discussions, and case studies.
• Networking Opportunities: Connect with a diverse range of professionals including researchers, scientists, clinicians, and industry leaders. Engage in meaningful conversations, forge new collaborations, and expand your professional network.
• Interactive Sessions: Participate in interactive sessions, workshops, and Q&A sessions to deepen your understanding of immune checkpoint inhibitors and combination therapies. Explore innovative approaches and novel strategies for improving patient outcomes.
• Early Bird Discount: Don't miss the chance to avail of the early bird discount, which will expire on August 31, 2023. Register before the deadline using the code "NGIOG20" to secure your spot at a reduced rate.

Main Highlights:
The main highlight of this annual conference is the comprehensive focus on immune checkpoint inhibitors and combination therapies. Attendees will gain insights into the latest advancements, clinical trials, and real-world experiences related to ICIs. The event will cover topics such as biomarkers, patient selection, clinical outcomes, toxicity management, resistance mechanisms, and the potential of combining ICIs with other treatment modalities.
Additionally, this conference will also cover the renowned topics in immune oncology:
• Updates in the development of ADC's and Bispecific Ab's
• Immune Checkpoint Inhibitors and Combinations
• Preclinical and Translational Immuno-Oncology Developments (Preclinical models for Immune checkpoint modulators)
• Biomarkers and Personalized Medicine in IO
• CAR-T Cell therapy, TCR Based-Cell Therapy
• Tumour microenvironment and Oncolytic Viruses
• Antibodies, tumour microenvironment and checkpoints
• Cancer vaccines, cancer biomarkers
Co-Located Events:
In addition to the Next-Gen Immuno-Oncology Conference, MarketsandMarkets is also hosting two co-located events at the same venue. These include the 6th Annual MarketsandMarkets Next-Gen Microbiome and Probiotics Conference and the 9th Annual MarketsandMarkets Biomarker and Companion Diagnostics Conference.

By registering for the Next-Gen Immuno-Oncology Conference, attendees will have the unique opportunity to attend these flagship events as well, thereby broadening their knowledge across multiple domains within the field of oncology.

Conclusion:
The MarketsandMarkets Next-Gen Immuno Oncology Conference is set to be a remarkable gathering of experts, innovators, and industry leaders in immuno-oncology. With a strong focus on immune checkpoint inhibitors and combinations, the conference promises to provide valuable insights, foster collaboration, and shape the future of cancer treatment. Don't miss out on the early bird discount, valid until August 31, 2023. Register today using the code "NGIOG20" to secure your participation and take advantage of this exceptional opportunity to attend co-located events, including the MarketsandMarkets Biomarker and Companion Diagnostics Conference. Join us in San Diego, USA on 8th - 9th February 2024, and be a part of the next generation of immuno-oncology advancements.

HURRY UP | REGISTER NOW AND AVAIL OF THE 20% DISCOUNT WITH CODE - NGIOSD20

Ms. Nayantara Patil
MarketsandMarkets™ Conferences
Tower B5, Office 101,
Magarpatta SEZ Hadapsar,
Pune - 411013,
India: +91 20 48598285
Email: events@marketsandmarkets.com

About MarketsandMarketsTM Conferences
One of the world's top companies for B2B conferences, summits, and corporate events is MarketsandMarketsTM Conferences. Our events give business executives, decision-makers, and subject-matter experts a forum for networking, knowledge exchange, and discussion of the most recent advancements in their specialised industries. We provide coverage for many different areas, including pharmaceuticals, healthcare, biotechnology, information technology, and many more. Excellent delegates from all over the world, such as Fortune 500 firms, SMEs, startups, and others, regularly attend our events.

This release was published on openPR.